These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34080391)

  • 1. [Pre-malignant and malignant diseases of the pancreas, a centralized and multidisciplinary approach].
    Meurisse N; Postal A; Dresse D; Geurde B; Honoré P; De Roover A
    Rev Med Liege; 2021 May; 76(5-6):525-529. PubMed ID: 34080391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial.
    Labori KJ; Lassen K; Hoem D; Grønbech JE; Søreide JA; Mortensen K; Smaaland R; Sorbye H; Verbeke C; Dueland S
    BMC Surg; 2017 Aug; 17(1):94. PubMed ID: 28841916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pre-malignant and malignant diseases of the esophagus, a centralized and multidisciplinary approach].
    Kohnen L; Honoré P; Kotzampassakis N; Dresse D; Legrand M; Loly JP; De Roover A
    Rev Med Liege; 2021 May; 76(5-6):530-534. PubMed ID: 34080392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pancreatic cancer: challenge of the facts.
    Beger HG; Rau B; Gansauge F; Poch B; Link KH
    World J Surg; 2003 Oct; 27(10):1075-84. PubMed ID: 12925907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant therapy for pancreas cancer: past lessons and future therapies.
    Sutton JM; Abbott DE
    World J Gastroenterol; 2014 Nov; 20(42):15564-79. PubMed ID: 25400440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer.
    Desai NV; Sliesoraitis S; Hughes SJ; Trevino JG; Zlotecki RA; Ivey AM; George TJ
    Cancer Med; 2015 Aug; 4(8):1224-39. PubMed ID: 25766842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
    Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
    Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
    Aslanian HR; Lee JH; Canto MI
    Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of surgical resection in treatment of pancreatic adenocarcinoma].
    Milosević P; Dolaji M; Milosević D; Ikonić N; Popović A; Veljković R
    Med Pregl; 2011; 64(9-10):448-52. PubMed ID: 22097109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does neoadjuvant therapy for pancreatic head adenocarcinoma increase postoperative morbidity? A systematic review of the literature with meta-analysis.
    Araujo RLC; Silva RO; de Pádua Souza C; Milani JM; Huguet F; Rezende AC; Gaujoux S
    J Surg Oncol; 2020 Apr; 121(5):881-892. PubMed ID: 31994193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in clinical research of pancreatic cancer: from "resection" to "cure"].
    Shen J; Guo SW; Jin G
    Zhonghua Wai Ke Za Zhi; 2019 Jan; 57(1):72-77. PubMed ID: 30612395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pancreatic adenocarcinoma: therapeutical update].
    Khosravi Shahi P; Díaz Muñoz de la Espada VM
    An Med Interna; 2005 Aug; 22(8):390-4. PubMed ID: 16351494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic neoadjuvant chemotherapy in modern pancreatic cancer treatment: a systematic review and meta-analysis.
    Rangarajan K; Pucher PH; Armstrong T; Bateman A; Hamady Z
    Ann R Coll Surg Engl; 2019 Sep; 101(7):453-462. PubMed ID: 31304767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.
    Turrini O; Ychou M; Moureau-Zabotto L; Rouanet P; Giovannini M; Moutardier V; Azria D; Delpero JR; Viret F
    Eur J Surg Oncol; 2010 Oct; 36(10):987-92. PubMed ID: 20828979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
    Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
    Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant strategy as initial treatment in resectable pancreatic cancer: concrete evidence of benefit.
    DE Felice F; Musio D; Raffetto N; Tombolini V
    Anticancer Res; 2014 Sep; 34(9):4673-6. PubMed ID: 25202043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic adenocarcinoma.
    Howard TJ
    Curr Probl Cancer; 1996; 20(5):281-328. PubMed ID: 8902402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short- and long-term results in operable pancreatic ductal adenocarcinomas from a cooperation between two departments gastroenterology-visceral surgery at non-university hospitals benchmarked to results of expert-centers].
    Dippold W; Sivanathan V; Statt K; Roitman M; Link KH
    Z Gastroenterol; 2017 Feb; 55(2):140-144. PubMed ID: 27875849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma.
    Motoi F; Unno M
    Jpn J Clin Oncol; 2020 May; 50(5):483-489. PubMed ID: 32083290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.